Project Grant R35GM158329

Award Date 8/1/25
Completion Date 5/31/30
Dollars Obligated $401K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded Vanderbilt University a 5-year, $422,569 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to develop new chemical reactions and reagents for generating enantioenriched organic compounds. These compounds serve as valuable precursors for synthesizing small molecule medicinal agents and biologically active natural products. The key focus is on creating stereoselective methods for producing...
The National Institute of General Medical Sciences (NIGMS) awarded a $356,423 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to Duke University, a leading private research institution. The grant, with a performance period from May 15, 2025 to February 28, 2030, supports three key research directions: (A) Developing efficient and accurate quantum mechanical (QM) methods based on density functional theory (DFT) for modeling biological systems. (B)...
The National Institute of General Medical Sciences (NIGMS) awarded a $635,246 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Georgia Tech Research Corporation. The grant, effective September 1, 2024 through June 30, 2028, supports the development of innovative bioorthogonal chemistry methods to facilitate interactions between biomolecules and small molecules for site-selective transformations in biological systems. The key objectives include: 1)...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $524,400.00 in funding to the Scripps Research Institute in La Jolla, CA. The grant, awarded on June 1, 2025, supports research aimed at developing novel chemical transformations and catalyst technologies to expedite the synthesis of structurally complex small molecules for drug discovery applications. Key goals...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), aims to develop new synthetic strategies to functionalize pyridine and diazine heterocycles. The $259,966 award to Colorado State University will fund research to explore three approaches for azine functionalization: 1) installing heterocyclic phosphonium salts and exploiting their reactivity for coupling reactions, 2) utilizing...
The National Institute of General Medical Sciences (NIGMS) awarded a $221,448 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Massachusetts Institute of Technology (MIT) to develop peptide catalysts for stereo- and site-selective C-C bond formation reactions. The research leverages automated fast-flow peptide synthesis and machine learning to design peptide catalysts containing non-natural residues that can achieve precise control over reaction...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,600,616 to the University of Wisconsin System for research aimed at engineering promiscuous enzymes to synthesize non-canonical amino acids (NCAAs) as new biological building blocks. The research encompasses mechanistic analysis of pyridoxal-phosphate dependent enzymes that catalyze C-C bond formation, as well as developing...
This $368,110 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to study the structures and properties of key enzymatic intermediates involved in oxygenase chemistry. The research aims to develop peptide-based synthetic models that can mimic the active sites and reactivity of non-heme iron and copper oxygenases, which are critical for metabolism, natural product...
This federal Project Grant award of $146,816.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research to develop general strategies for the biocatalytic synthesis of N-N and C-N heterobiaryl atropisomers, a class of medicinally relevant chiral compounds that are difficult to obtain through other methods. The research outlined will employ bioinformatic techniques to...
The U.S. National Institute of General Medical Sciences (NIGMS) awarded a $213,563.00 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Regents of the University of Colorado, effective September 5, 2024 through August 31, 2026. The grant funds research to develop a new class of "shape-shifting" cyclic peptides that can rapidly assume diverse structural isomers, allowing them to interact with multiple biological targets. The project aims to create a...

The National Institute of General Medical Sciences (NIGMS) awarded a $401,233 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) federal grant program to Duke University, effective August 1, 2025 through May 31, 2030. The grant supports the development of new catalytic selective amination methods and aminofunctionalization cascades to expedite the synthesis and study of structurally diverse, nitrogen-containing molecules as probes and leads for advancing the understanding and treatment of human disease. The research aims to establish a chemical platform that can streamline the creation of novel nitrogen-containing molecules from readily available starting materials like alkenes, dienes, cyclopropanes, and functional molecules. Successful implementation of these studies is expected to greatly facilitate the synthesis and investigation of a wide range of nitrogen-containing molecules that are difficult or impossible to access with current technologies, benefiting organic synthesis, medicinal chemistry, biomedical research, and drug discovery.

Generated 8/5/25, 4:23 AM